Search Results - "BUSQUETS, Silvia"
-
1
Cachexia and sarcopenia: mechanisms and potential targets for intervention
Published in Current opinion in pharmacology (01-06-2015)“…Highlights • Cachexia and sarcopenia share common trends: altered protein synthesis and degradation. • Cachexia and sarcopenia are both driven by inflammation…”
Get full text
Journal Article -
2
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function
Published in Journal of molecular biology (12-07-2019)“…Cancer cachexia is a multifactorial syndrome characterized by anorexia, weight loss and muscle wasting that impairs patients' quality of life and survival. Aim…”
Get full text
Journal Article -
3
Therapeutic strategies against cancer cachexia
Published in European journal of translational myology (27-02-2019)“…Cancer cachexia has two main components: anorexia and metabolic alterations. The main changes associated with the development of this multi-organic syndrome…”
Get full text
Journal Article -
4
Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and [beta]-2 agonist
Published in International journal of cancer (15-04-2016)“…Formoterol is a highly potent [beta]2-adrenoceptor-selective agonist, which is a muscle growth promoter in many animal species. Myostatin/activin inhibition…”
Get full text
Journal Article -
5
Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: Altered energetic efficiency?
Published in Biochimica et biophysica acta (01-03-2013)“…Cachexia is a wasting condition that manifests in several types of cancer, and the main characteristic is the profound loss of muscle mass. The Yoshida AH-130…”
Get full text
Journal Article -
6
Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
Published in Journal of cachexia, sarcopenia and muscle (01-03-2012)“…Background Cachexia is a multiorganic syndrome associated with cancer, characterized by body weight loss, muscle and adipose tissue wasting and inflammation…”
Get full text
Journal Article -
7
Effects of the beta2 agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia
Published in Biochimie (01-06-2018)“…Muscle mass loss and wasting are characteristic features of patients with chronic conditions including cancer. Beta-adrenoceptors attenuate muscle wasting. We…”
Get full text
Journal Article -
8
Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
Published in Oncotarget (22-12-2015)“…Cancer cachexia is a syndrome characterized by loss of skeletal muscle mass, inflammation, anorexia and anemia, contributing to patient fatigue and reduced…”
Get full text
Journal Article -
9
Differential structural features in soleus and gastrocnemius of carnitine‐treated cancer cachectic rats
Published in Journal of cellular physiology (01-01-2020)“…Muscle wasting is associated with chronic diseases and cancer. Elucidation of the biological mechanism involved in the process of muscle mass loss and cachexia…”
Get full text
Journal Article -
10
Are there any benefits of exercise training in cancer cachexia?
Published in Journal of cachexia, sarcopenia and muscle (01-06-2012)“…Cancer cachexia is a complex syndrome characterized by inflammation, body weight loss, muscle, and adipose tissue wasting that is responsible for the death of…”
Get full text
Journal Article -
11
Nonmuscle Tissues Contribution to Cancer Cachexia
Published in Mediators of Inflammation (01-01-2015)“…Cachexia is a syndrome associated with cancer, characterized by body weight loss, muscle and adipose tissue wasting, and inflammation, being often associated…”
Get full text
Journal Article -
12
Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats
Published in Antioxidants & redox signaling (01-02-2010)“…In fast- and slow-twitch limb and heart muscles of cachectic rats, redox balance and muscle structure were explored. The nature of the oxidatively modified…”
Get more information
Journal Article -
13
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia
Published in International journal of cancer (01-11-2012)“…Cachexia is a common co‐morbidity in cancer occurring in up to 80% of patients depending on the type of cancer. Uric acid (UA), the end‐product of the purine…”
Get full text
Journal Article -
14
A Rat Immobilization Model Based on Cage Volume Reduction: A Physiological Model for Bed Rest?
Published in Frontiers in physiology (29-03-2017)“…Bed rest has been an established treatment in the past prescribed for critically illness or convalescing patients, in order to preserve their body metabolic…”
Get full text
Journal Article -
15
A multifactorial anti‐cachectic approach for cancer cachexia in a rat model undergoing chemotherapy
Published in Journal of cachexia, sarcopenia and muscle (01-03-2016)“…Background The effectiveness of drugs aimed at counteracting cancer cachexia is generally tested in pre‐clinical rodent models, where only the tumour‐induced…”
Get full text
Journal Article -
16
Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
Published in Journal of cachexia, sarcopenia and muscle (01-06-2023)“…Background It is known that S‐pindolol attenuates muscle loss in animal models of cancer cachexia and sarcopenia. In cancer cachexia, it also significantly…”
Get full text
Journal Article -
17
Formoterol in the treatment of experimental cancer cachexia: effects on heart function
Published in Journal of cachexia, sarcopenia and muscle (01-12-2014)“…Background and aims Formoterol is a highly potent β2-adrenoceptor-selective agonist, which is a muscle growth promoter in many animal species, resulting in…”
Get full text
Journal Article -
18
Anabolic deficits and divergent unfolded protein response underlie skeletal and cardiac muscle growth impairments in the Yoshida hepatoma tumor model of cancer cachexia
Published in Physiological reports (01-09-2024)“…Cancer cachexia manifests as whole body wasting, however, the precise mechanisms governing the alterations in skeletal muscle and cardiac anabolism have yet to…”
Get full text
Journal Article -
19
Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy
Published in Frontiers in oncology (03-01-2024)“…Even though doxorubicin (DOX) chemotherapy promotes intense muscle wasting, this drug is still widely used in clinical practice due to its remarkable…”
Get full text
Journal Article -
20
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes
Published in Frontiers in physiology (18-12-2018)Get full text
Journal Article